Global patent index - EP 1060255 A2

EP 1060255 A2 2000-12-20 - HIGHLY CRYSTALLINE UROKINASE

Title (en)

HIGHLY CRYSTALLINE UROKINASE

Title (de)

HOCHKRISTALLINE UROKINASE

Title (fr)

UROKINASE FORTEMENT CRISTALLINE

Publication

EP 1060255 A2 (EN)

Application

EP 99909895 A

Priority

  • US 9904992 W
  • US 3636198 A
  • US 26446899 A

Abstract (en)

[origin: WO9945105A2] The present disclosure describes a biologically active modified urokinase and high resolution crystalline forms of modified urokinase. Polynucleotides which encode modified urokinase and methods for making modified urokinase are also disclosed.

IPC 1-7 (main, further and additional classification)

C12N 15/58; C12N 5/10; C12N 9/72; C12N 15/86; C12P 21/02

IPC 8 full level (invention and additional information)

C12N 15/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 9/50 (2006.01); C12N 9/72 (2006.01)

CPC (invention and additional information)

C12N 9/6462 (2013.01); C12Y 304/21073 (2013.01)

Citation (search report)

See references of WO 9945105A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

EPO simple patent family

WO 9945105 A2 19990910; WO 9945105 A3 20000309; CA 2322622 A1 19990910; EP 1060255 A2 20001220; JP 2003521222 A 20030715

INPADOC legal status

2006-04-12 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20051001

2000-12-20 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20000825

2000-12-20 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE